Lactobacillus casei Shirota does not decrease the food allergic response to peanut extract in Brown Norway rats☆

Jonge, Jonathan D. de; Ezendam, Janine; Knippels, L.M.J.; Penninks, André; Pieters, Raymond; Loveren, Henk Van

doi:10.1016/j.tox.2008.04.016

Cited by 11 publications

(12 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For instance, it has been shown that LCS partially protected mice in a peanut sensitization model. Differently, the same probiotic strain did not decrease the food allergic response to peanut extract in Brown Norway rats (De Jonge et al 2008;Meijerink et al 2012). Bifidobacterium lactis Bb12, for instance, have yielded a high IL-10/IL-12 ratio after co-incubation with PBMCs being regarded as an anti-inflammatory strain favouring type-2 T-cell responses.…”

Section: Relevance Of Preclinical Studiesmentioning

confidence: 88%

See 1 more Smart Citation

Immunotherapy of allergic diseases using probiotics or recombinant probiotics

et al. 2013

View full text Add to dashboard Cite

SummaryAllergic diseases affect up to 30% of the western population, and their prevalence is increasing. Probiotics are able to modulate the mucosal immune response, and clinical trials demonstrated that specific strains, especially lactic acid bacteria (LAB) ones, reduce allergic symptoms. Moreover, the use of recombinant probiotics has been evaluated as possible strategies for the immunotherapy of allergic diseases. The production and delivery of allergens by recombinant LAB in concert with their ability to induce a Th1-type immune response have been shown to be a promising mucosal vaccination strategy in mouse model. The aim of this article is to review the applications of probiotics in allergy immunotherapy with a special focus on recombinant LAB delivering proteins or DNA.

show abstract

Section: Relevance Of Preclinical Studiesmentioning

confidence: 88%

“…Differently, the same probiotic strain did not decrease the food allergic response to peanut extract in Brown Norway rats (De Jonge et al . ; Meijerink et al . ).…”

Section: Probiotics and Allergy Treatmentmentioning

confidence: 99%

Immunotherapy of allergic diseases using probiotics or recombinant probiotics

et al. 2013

View full text Add to dashboard Cite

show abstract

“…131 Similarly, LGG and Bifidobacterium animalis MB5 was demonstrated by Finamore et al to induce intestinal but not systemic antigen-specific hyporesponsiveness in OVA-immunized rats. 132 LcS was also shown not to decrease allergic response to peanut extract in Brown Norway rats in a study by de Jonge et al 133 Moreover, a few randomized controlled trials also showed no effects of probiotics, specifically LGG or Lactobacillus acidophilus, in protection against cow's milk allergy in infancy. 97,105,117,121 Osborn and Sinn 134 reviewed 6 studies enrolling 1549 infants and reported no other benefits of probiotics for food hypersensitivity as well.…”

Section: Food Allergy and Anaphylaxismentioning

confidence: 97%

RETRACTED: Preventative and Therapeutic Role of Probiotics in Various Allergic and Autoimmune Disorders: An Up-to-Date Literature Review of Essential Experimental and Clinical Data

Özdemir

2012

J Evid Based Complementary Altern Med

View full text Add to dashboard Cite

“Preventative and Therapeutic Role of Probiotics in Various Allergic and Autoimmune Disorders: An Up-to-Date Literature Review of Essential Experimental and Clinical Data,” by Öner Özdemir, Journal of Evidence-Based Complementary & Alternative Medicine, April 2013 (18:2), doi: 10.1177/2156587212461279 .This article has been retracted due to unattributed overlap with material from other sources and due to duplicate publication.The unattributed excerpts in the article were taken from the following sources: Ouwehand AC. Antiallergic effects of probiotics. J Nutr. 2007;137(3 suppl 2):794S–797S. Saavedra JM. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr Clin Pract. 2007;22:351–365. doi:10.1177/0115426507022003351. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut. 2005;54:317–320. doi:10.1136/gut.2004.053785. Michail S. The role of probiotics in allergic diseases. Allergy Asthma Clin Immunol. 2009;5:5. doi:10.1186/1710-1492-5-5. The author also published the following works that include significant unattributed excerpts from the article: Özdemir Ö, Erol AY. Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings. BioMed Res Int. 2013;2013:932391. doi:10.1155/2013/932391. Özdemir Ö. The role of probiotics in atopic dermatitis prevention and therapy. In: Esparza-Gordillo J, Dekio I, eds. Atopic Dermatitis: Disease Etiology and Clinical Management. Rijeka, Croatia: InTech; 2012:353–386. doi:10.5772/25301.

show abstract

“…Other studies using the OVA model of egg allergy have demonstrated anti-allergic effects for several probiotic species including L. acidophilus (Kim et al, 2008; Finamore et al, 2012), B. lactis (Kim et al, 2008), LGG (Finamore et al, 2012), and L. lactis (Zuercher et al, 2012). L. casei Shirota was unable to suppress peanut allergic responses in rats characterized by increased levels of both IgG and IgE as well as IFN-γ and IL-4 levels secreted by in vitro stimulated splenic and mesenteric lymph node cells (de Jonge et al, 2008). …”

Section: Evidence For Probiotic Effects In Animal Models Of Allergic mentioning

confidence: 99%

Probiotic Therapy as a Novel Approach for Allergic Disease

Toh¹,

Anzela²,

Tang³

et al. 2012

Front. Pharmacol.

View full text Add to dashboard Cite

The prevalence of allergic disease has increased dramatically in Western countries over the past few decades. The hygiene hypothesis, whereby reduced exposure to microbial stimuli in early life programs the immune system toward a Th2-type allergic response, is suggested to be a major mechanism to explain this phenomenon in developed populations. Such microbial exposures are recognized to be critical regulators of intestinal microbiota development. Furthermore, intestinal microbiota has an important role in signaling to the developing mucosal immune system. Intestinal dysbiosis has been shown to precede the onset of clinical allergy, possibly through altered immune regulation. Existing treatments for allergic diseases such as eczema, asthma, and food allergy are limited and so the focus has been to identify alternative treatment or preventive strategies. Over the past 10 years, a number of clinical studies have investigated the potential of probiotic bacteria to ameliorate the pathological features of allergic disease. This novel approach has stemmed from numerous data reporting the pleiotropic effects of probiotics that include immunomodulation, restoration of intestinal dysbiosis as well as maintaining epithelial barrier integrity. In this mini-review, the emerging role of probiotics in the prevention and/or treatment of allergic disease are discussed with a focus on the evidence from animal and human studies.

show abstract

Lactobacillus casei Shirota does not decrease the food allergic response to peanut extract in Brown Norway rats☆

Cited by 11 publications

References 30 publications

Immunotherapy of allergic diseases using probiotics or recombinant probiotics

Immunotherapy of allergic diseases using probiotics or recombinant probiotics

RETRACTED: Preventative and Therapeutic Role of Probiotics in Various Allergic and Autoimmune Disorders: An Up-to-Date Literature Review of Essential Experimental and Clinical Data

Probiotic Therapy as a Novel Approach for Allergic Disease

Contact Info

Product

Resources

About